AChE-IN-47 is an acetylcholinesterase (AChE) inhibitor with an IC50 of 0.24 μM; it inhibits the self-aggregation of amyloid-beta peptides and exhibits neuroprotective effects by effectively suppressing the accumulation of intracellular reactive oxygen species (ROS).